These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1388 related articles for article (PubMed ID: 28799247)

  • 1. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
    Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented endothelial l-arginine transport ameliorates pressure-overload-induced cardiac hypertrophy.
    Rajapakse NW; Johnston T; Kiriazis H; Chin-Dusting JP; Du XJ; Kaye DM
    Exp Physiol; 2015 Jul; 100(7):796-804. PubMed ID: 25958845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.
    Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P
    J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
    Yoshioka K; Otani H; Shimazu T; Fujita M; Iwasaka T; Shiojima I
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1782-91. PubMed ID: 26408540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
    Ye Y; Gong H; Wang X; Wu J; Wang S; Yuan J; Yin P; Jiang G; Li Y; Ding Z; Zhang W; Zhou J; Ge J; Zou Y
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):628-39. PubMed ID: 25806688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
    Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
    Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-kinase inhibition reverses impaired Ca
    Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
    Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate Exercise in Spontaneously Hypertensive Rats Is Unable to Activate the Expression of Genes Linked to Mitochondrial Dynamics and Biogenesis in Cardiomyocytes.
    Quiroga C; Mancilla G; Oyarzun I; Tapia A; Caballero M; Gabrielli LA; Valladares-Ide D; Del Campo A; Castro PF; Verdejo HE
    Front Endocrinol (Lausanne); 2020; 11():546. PubMed ID: 32973679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
    Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
    Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ
    Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice.
    Matsushita N; Ishida N; Ibi M; Saito M; Sanbe A; Shimojo H; Suzuki S; Koepsell H; Takeishi Y; Morino Y; Taira E; Sawa Y; Hirose M
    Int Heart J; 2018 Sep; 59(5):1123-1133. PubMed ID: 30101852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
    Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H
    Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic characterization reveals novel mechanisms underlying the valosin-containing protein-mediated cardiac protection against heart failure.
    Zhou N; Chen X; Xi J; Ma B; Leimena C; Stoll S; Qin G; Wang C; Qiu H
    Redox Biol; 2020 Sep; 36():101662. PubMed ID: 32795937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
    Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.